Search
Search Results
##search.searchResults.foundPlural##
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3293PDF: 943HTML: 2961 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2152PDF: 1710HTML: 382 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2140PDF: 1000HTML: 4078Cover Letter: 224Figure 1: 235Figure 2: 233Table 1: 206 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1861PDF: 722HTML: 2114Untitled: 222Untitled: 156Untitled: 176Untitled: 160Untitled: 168Untitled: 183Untitled: 189 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1064PDF: 1171Suppl. Files: 569HTML: 89 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3034PDF: 911HTML: 1998 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
793PDF: 93HTML: 145 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1980PDF: 825HTML: 2206Table 1: 181Table 2: 201Table 3: 194Table 4: 197Table 5: 195Tble 6: 187Cover Letter: 208Greene Tab.7: 198 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2867PDF: 853HTML: 6529Untitled: 230Untitled: 195Untitled: 208Untitled: 218 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1722PDF: 1103HTML: 10702Untitled: 192 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1189PDF: 843HTML: 3364 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2052PDF: 840HTML: 258 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3594PDF: 1507HTML: 4414CoverLetter: 186Figure1: 198 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1377PDF: 847HTML: 139 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2599PDF: 751HTML: 2309 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1797PDF: 1081HTML: 255 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2247PDF: 950HTML: 5069Cover Letter: 172Figure 2: 164Figure 1: 175Figure 3: 198Figure 4: 170Figure Legend: 188Table 1: 192Table 2: 184Table 3: 183 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2479PDF: 1316HTML: 1788CoverLetter: 184 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1339PDF: 1230HTML: 457 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3576PDF: 2505HTML: 1492 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2631PDF: 1624HTML: 2373Table1: 191 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3633PDF: 896HTML: 6719 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1294PDF: 500HTML: 205 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1489PDF: 1079HTML: 223 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1131PDF: 499HTML: 243 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4140PDF: 1714HTML: 1027 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2246PDF: 1053HTML: 1989Characteristic of study group: 204 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2597PDF: 807HTML: 5223 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1715PDF: 698HTML: 3800 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1635PDF: 819HTML: 175 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3929PDF: 1485HTML: 8517 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2187PDF: 1597HTML: 312 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1768PDF: 1178HTML: 252 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2479HTML: 279PDF: 883







